Thomas Woiwode's Net Worth
$75 Million
Who is Thomas Woiwode?
Thomas Woiwode has an estimated net worth of $75 Million. This is based on reported shares across multiple companies, which include Gritstone bio, Inc., CRISPR Therapeutics AG, Adverum Biotechnologies, Inc., Aligos Therapeutics, Inc., Tempest Therapeutics, Inc., Passage BIO, Inc., and Audentes Therapeutics, Inc..
SEC CIK
Thomas Woiwode's CIK is 0001619294
Past Insider Trading and Trends
2016 was Thomas Woiwode's most active year for acquiring shares with 34 total transactions. Thomas Woiwode's most active month to acquire stocks was the month of September. 2018 was Thomas Woiwode's most active year for disposing of shares, totalling 36 transactions. Thomas Woiwode's most active month to dispose stocks was the month of March. 2020 saw Thomas Woiwode paying a total of $16,100,000.39 for 14,648,705 shares, this is the most they've acquired in one year. In 2018 Thomas Woiwode cashed out on 4,238,868 shares for a total of $27,674,444.26, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Gritstone bio, Inc. (GRTS) Snapshot price: $2.32
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -32.99% | -444.62K |
—
|
—
| 903.09K |
Scheduled
|
Aug 25
| ||
Form 4
|
∞
| 1.35M |
$3.71 | $5,000,000.39 | 1.35M |
Dec 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
∞
| 3.1M |
—
|
—
| 3.1M |
Oct 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CRISPR Therapeutics AG (CRSP) Snapshot price: $66.91
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
| -6.43% | -44.00K |
$57.99 | -$2,551,440.00 | 640.01K |
May 15
| |||
Form 4
| -4.26% | -121.36K |
$50.86 | -$6,115,872.59 | 2.73M |
Scheduled
|
May 7 - May 8
| ||
Form 4
| -2.03% | -30.57K |
$50.28 | -$1,537,137.92 | 1.48M |
Scheduled
|
Apr 30
| ||
Form 4
| -6.84% | -222.26K |
$50.08 | -$11,136,437.01 | 3.03M |
Scheduled
|
Apr 26 - Apr 27
| ||
Form 4
| -1.30% | -22.84K |
$50.90 | -$1,164,655.40 | 1.73M |
Scheduled
|
Apr 24
| ||
Form 4
| -13.00% | -599.67K |
$50.83 | -$5,168,901.34 | 4.01M |
Scheduled
|
Apr 20 - Apr 23
| ||
Form 4
| -38.15% | -3.06K |
$20.29 | -$62,070.47 | 4.96K |
Scheduled
|
Dec 22
| ||
Form 4
| -19.16% | -1.90K |
$20.21 | -$38,405.85 | 8.02K |
Scheduled
|
Nov 24 - Nov 27
| ||
Form 4
| -33.19% | -2.29M |
—
|
—
| 4.62M |
Sep 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
| +2,783.12% | 6.67M |
$14.00 |
—
| 6.91M |
Oct 18 - Oct 24
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Adverum Biotechnologies, Inc. (ADVM) Snapshot price: $2.4
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
| +211.67% | 12.78K |
—
|
—
| 18.82K |
Dec 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
| +47.69% | 22.73K |
—
|
—
| 70.38K |
Jun 12
| |||
Form 4
| +4.89% | 2.22K |
—
|
—
| 47.65K |
Apr 28
| |||
Form 4
| +8.88% | 3.7K |
—
|
—
| 45.43K |
Mar 31
| |||
Form 4
| +9.94% | 3.77K |
—
|
—
| 41.73K |
Feb 28
| |||
Form 4
| +10.00% | 3.45K |
—
|
—
| 37.95K |
Jan 31
| |||
Form 4
| +11.11% | 3.45K |
—
|
—
| 34.5K |
Dec 30
| |||
Form 4
| +12.74% | 3.51K |
—
|
—
| 31.05K |
Nov 30
| |||
Form 4
| +14.03% | 3.39K |
—
|
—
| 27.55K |
Oct 31
| |||
Form 4
|
∞
| 24.16K |
—
|
—
| 24.16K |
May 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aligos Therapeutics, Inc. (ALGS) Snapshot price: $0.72
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
| -24.86% | -483.75K |
—
|
—
| 1.46M |
Scheduled
|
Jun 11
| ||
Form 4
| -19.91% | -483.75K |
—
|
—
| 1.95M |
Scheduled
|
Apr 26
| ||
Form 4
|
∞
| 3.29M |
$15.00 |
—
| 3.29M |
Oct 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Tempest Therapeutics, Inc. (TPST) Snapshot price: $4.165
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
∞
| 2.12M |
$2.36 | $4,999,999.84 | 2.12M |
Apr 29
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
∞
| 2.18M |
—
|
—
| 2.18M |
Jun 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||